Pathogenesis of type 1 diabetes mellitus: interplay between enterovirus and host (original) (raw)
Gale, E. A. The rise of childhood type 1 diabetes in the 20th century. Diabetes51, 3353–3361 (2002). ArticleCASPubMed Google Scholar
Jaïdane, H. & Hober, D. Role of coxsackievirus B4 in the pathogenesis of type 1 diabetes. Diabetes Metab.34, 537–548 (2008). ArticlePubMedCAS Google Scholar
Kondrashova, A. et al. A six-fold gradient in the incidence of type 1 diabetes at the eastern border of Finland. Ann. Med.37, 67–72 (2005). ArticlePubMed Google Scholar
Nejentsev, S. et al. Localization of type 1 diabetes susceptibility to the MHC class I genes HLA-B and HLA-A. Nature450, 887–892 (2007). ArticleCASPubMedPubMed Central Google Scholar
Smyth, D. J. A genome-wide association study of nonsynonymous SNPs identifies a type 1 diabetes locus in the interferon-induced helicase (IFIH1) region. Nat. Genet.38, 617–619 (2006). ArticleCASPubMed Google Scholar
Todd, J. A. Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat. Genet.39, 857–864 (2007). ArticleCASPubMedPubMed Central Google Scholar
Cooper, J. D. Meta-analysis of genome-wide association study data identifies additional type 1 diabetes risk loci. Nat. Genet.40, 1399–1401 (2008). ArticleCASPubMedPubMed Central Google Scholar
Jaïdane, H. et al. Coxsackievirus B4 and type 1 diabetes pathogenesis: contribution of animal models. Diabetes Metab. Res. Rev.25, 591–603 (2009). ArticlePubMedCAS Google Scholar
Bach, J. F. The effect of infections on susceptibility to autoimmune and allergic diseases. N. Engl. J. Med.347, 911–920 (2002). ArticlePubMed Google Scholar
Goldberg, E. & Krause, I. Infection and type 1 diabetes mellitus—a two edged sword? Autoimmun. Rev.8, 682–686 (2009). ArticleCASPubMed Google Scholar
Yoon, J. W. A new look at viruses in type 1 diabetes. Diabetes Metab. Rev.11, 83–107 (1995). ArticleCASPubMed Google Scholar
Richer, M. J. & Horwitz, M. S. Coxsackievirus infection as an environmental factor in the etiology of type 1 diabetes. Autoimmun. Rev.8, 611–615 (2009). ArticleCASPubMed Google Scholar
Haverkos, H. W., Battula, N., Drotman, D. P. & Rennert, O. M. Enteroviruses and type 1 diabetes mellitus. Biomed. Pharmacother.57, 379–385 (2003). ArticleCASPubMed Google Scholar
Hyöty, H. & Taylor, K. W. The role of viruses in human diabetes. Diabetologia45, 1353–1361 (2002). ArticlePubMedCAS Google Scholar
Nairn, C., Galbraith, D. N., Taylor, K. W. & Clements, G. B. Enterovirus variants in the serum of children at the onset of type 1 diabetes mellitus. Diabet. Med.16, 509–513 (1999). ArticleCASPubMed Google Scholar
Yin, H., Berg, A. K., Tuvemo, T. & Frisk, G. Enterovirus RNA is found in peripheral blood mononuclear cells in a majority of type 1 diabetic children at onset. Diabetes51, 1964–1971 (2002). ArticleCASPubMed Google Scholar
Moya-Suri, V. et al. Enterovirus RNA sequences in sera of schoolchildren in the general population and their association with type 1-diabetes-associated autoantibodies. J. Med. Microbiol.54, 879–883 (2005). ArticleCASPubMed Google Scholar
Sarmiento, L. et al. Occurrence of enterovirus RNA in serum of children with newly diagnosed type 1 diabetes and islet cell autoantibody-positive subjects in a population with a low incidence of type 1 diabetes. Autoimmunity40, 540–545 (2007). ArticleCASPubMed Google Scholar
Elfaitouri, A. et al. Recent enterovirus infection in type 1 diabetes: evidence with a novel IgM method. J. Med. Virol.79, 1861–1867 (2007). ArticleCASPubMed Google Scholar
Chehadeh, W. et al. Increased level of interferon-α in blood of patients with insulin-dependent diabetes mellitus: relationship with coxsackievirus B infection. J. Infect. Dis.181, 1929–1939 (2000). ArticleCASPubMed Google Scholar
Elfving, M. et al. Maternal enterovirus infection during pregnancy as a risk factor in offspring diagnosed with type 1 diabetes between 15 and 30 years of age. Exp. Diabetes Res.2008, 271958 (2008). ArticlePubMedPubMed CentralCAS Google Scholar
Imagawa, A., Hanafusa, T., Makino, H., Miyagawa, J. I. & Juto, P. High titres of IgA antibodies to enterovirus in fulminant type-1 diabetes. Diabetologia48, 290–293 (2005). ArticleCASPubMed Google Scholar
Akatsuka, H. et al. A case of fulminant type 1 diabetes with coxsackie B4 virus infection diagnosed by elevated serum levels of neutralizing antibody. Diabetes Res. Clin. Pract.84, e50–e52 (2009). ArticleCASPubMed Google Scholar
Gerling, I., Chatterjee, N. K. & Nejman, C. Coxsackievirus B4-induced development of antibodies to 64,000-Mr islet autoantigen and hyperglycemia in mice. Autoimmunity10, 49–56 (1991). ArticleCASPubMed Google Scholar
Hyöty, H. et al. A prospective study of the role of coxsackie B and other enterovirus infections in the pathogenesis of IDDM. Childhood Diabetes in Finland (DiMe) Study Group. Diabetes44, 652–657 (1995). ArticlePubMed Google Scholar
Sadeharju, K., Knip, M., Hiltunen, M., Akerblom, H. K. & Hyöty, H. The HLA-DR phenotype modulates the humoral immune response to enterovirus antigens. Diabetologia46, 1100–1105 (2003). ArticleCASPubMed Google Scholar
Dahlquist, G. G., Boman, J. E. & Juto, P. Enteroviral RNA and IgM antibodies in early pregnancy and risk for childhood-onset IDDM in offspring. Diabetes Care22, 364–365 (1999). ArticleCASPubMed Google Scholar
Dahlquist, G. G., Ivarsson, S., Lindberg, B. & Forsgren. M. Maternal enteroviral infection during pregnancy as a risk factor for childhood IDDM. A population-based case-control study. Diabetes44, 408–413 (1995). ArticleCASPubMed Google Scholar
Foulis, A. K., Farquharson, M. A. & Meager, A. Immunoreactive alpha-interferon in insulin-secreting beta cells in type 1 diabetes mellitus. Lancet2, 1423–1427 (1987). ArticleCASPubMed Google Scholar
Huang, X. et al. Interferon expression in the pancreases of patients with type I diabetes. Diabetes44, 658–664 (1995). ArticleCASPubMed Google Scholar
Dotta, F. et al. Coxsackie B4 virus infection of beta cells and natural killer cell insulitis in recent-onset type 1 diabetic patients. Proc. Natl Acad. Sci. USA104, 5115–5120 (2007). ArticleCASPubMedPubMed Central Google Scholar
Yoon, J. W., Austin, M., Onodera, T. & Notkins, A. L. Isolation of a virus from the pancreas of a child with diabetic ketoacidosis (virus-induced diabetes mellitus). N. Engl. J. Med.300, 1173–1179 (1979). ArticleCASPubMed Google Scholar
Ylipaasto, P. et al. Enterovirus infection in human pancreatic islet cells, islet tropism in vivo and receptor involvement in cultured islet beta cells. Diabetologia47, 225–239 (2004). ArticleCASPubMed Google Scholar
Richardson, S. J., Willcox, A., Bone, A. J., Foulis, A. K. & Morgan, N. G. The prevalence of enteroviral capsid protein vp1 immunostaining in pancreatic islets in human type 1 diabetes. Diabetologia5, 1143–1151 (2009). ArticleCAS Google Scholar
Oikarinen, M. et al. Analysis of pancreas tissue in a child positive for islet cell antibodies. Diabetologia51, 1796–1802 (2008). ArticleCASPubMed Google Scholar
Oldstone, M. B. Prevention of type I diabetes in nonobese diabetic mice by virus infection. Science239, 500–502 (1988). ArticleCASPubMed Google Scholar
Christen, U. et al. Cure of prediabetic mice by viral infections involves lymphocyte recruitment along an IP-10 gradient. J. Clin. Invest.113, 74–84 (2004). ArticleCASPubMedPubMed Central Google Scholar
Viskari, H. et al. Relationship between the incidence of type 1 diabetes and maternal enterovirus antibodies: time trends and geographical variation. Diabetologia48, 1280–1287 (2005). ArticleCASPubMed Google Scholar
Roivainen, M. et al. Mechanisms of coxsackievirus-induced damage to human pancreatic beta-cells. J. Clin. Endocrinol. Metab.85, 432–440 (2000). CASPubMed Google Scholar
Chehadeh, W. et al. Persistent infection of human pancreatic islets by coxsackievirus B is associated with alpha interferon synthesis in beta cells. J. Virol.74, 10153–10164 (2000). ArticleCASPubMedPubMed Central Google Scholar
Frisk, G. & Diderholm, H. Tissue culture of isolated human pancreatic islets infected with different strains of coxsackievirus B4: assessment of virus replication and effects on islet morphology and insulin release. Int. J. Exp. Diabetes Res.1, 165–175 (2000). ArticleCASPubMedPubMed Central Google Scholar
Klemola, P., Kaijalainen, S., Ylipaasto, P. & Roivainen, M. Diabetogenic effects of the most prevalent enteroviruses in Finnish sewage. Ann. NY Acad. Sci.1150, 210–212 (2008). ArticlePubMed Google Scholar
Szopa, T. M., Ward, T., Dronfield, D. M., Portwood, N. D. & Taylor, K. W. Coxsackie B4 viruses with the potential to damage beta cells of the islets are present in clinical isolates. Diabetologia33, 325–328 (1990). ArticleCASPubMed Google Scholar
Roivainen, M. Enteroviruses: new findings on the role of enteroviruses in type 1 diabetes. Int. J. Biochem. Cell. Biol.38, 721–725 (2005). ArticlePubMedCAS Google Scholar
Ylipaasto, P. et al. Global profiling of coxsackievirus- and cytokine-induced gene expression in human pancreatic islets. Diabetologia48, 1510–1522 (2005). ArticleCASPubMed Google Scholar
Yoon, J. W., Onodera, T. & Notkins, A. L. Virus-induced diabetes mellitus. XV. Beta cell damage and insulin-dependent hyperglycemia in mice infected with coxsackie virus B4. J. Exp. Med.148, 1068–1080 (1978). ArticleCASPubMed Google Scholar
Coppieters, K. T. & von Herrath, M. G. Histopathology of type 1 diabetes: old paradigms and new insights. Rev. Diabet. Stud.6, 85–96 (2009). ArticlePubMedPubMed Central Google Scholar
Atkinson, M. A. & Gianani, R. The pancreas in human type 1 diabetes: providing new answers to age-old questions. Curr. Opin. Endocrinol. Diabetes Obes.16, 279–285 (2009). ArticlePubMed Google Scholar
Tracy, S. & Drescher, K. M. Coxsackievirus infections and NOD mice relevant models of protection from, and induction of, type 1 diabetes. Ann. NY Acad. Sci.1103, 143–151 (2007). ArticleCASPubMed Google Scholar
Tracy, S. et al. Toward testing the hypothesis that group B coxsackieviruses (CVB) trigger insulin-dependent diabetes: inoculating nonobese diabetic mice with CVB markedly lowers diabetes incidence. J. Virol.76, 12097–12111 (2002). ArticleCASPubMedPubMed Central Google Scholar
Bortell, R., Pino, S. C., Greiner, D. L., Zipris, D. & Rossini, A. A. Closing the circle between the bedside and the bench: Toll-like receptors in models of virally induced diabetes. Ann. NY Acad. Sci.1150, 112–122 (2008). ArticleCASPubMed Google Scholar
Eizirik, D. L., Colli, M. L. & Ortis, F. The role of inflammation in insulitis and beta-cell loss in type 1 diabetes. Nat. Rev. Endocrinol.5, 219–226 (2009). ArticleCASPubMed Google Scholar
Hultcrantz, M. et al. Interferons induce an antiviral state in human pancreatic islet cells. Virology367, 92–101 (2007). ArticleCASPubMed Google Scholar
Wen, L., Peng, J., Li, Z. & Wong, F. S. The effect of innate immunity on autoimmune diabetes and the expression of Toll-like receptors on pancreatic islets. J. Immunol.172, 3173–3180 (2004). ArticleCASPubMed Google Scholar
Rasschaert, J. et al. Toll-like receptor 3 and STAT-1 contribute to double-stranded RNA+ interferon-gamma-induced apoptosis in primary pancreatic beta-cells. J. Biol. Chem.280, 33984–33991 (2005). ArticleCASPubMed Google Scholar
Liu, D., Cardozo, A. K., Darville, M. I. & Eizirik, D. L. Double-stranded RNA cooperates with interferon-gamma and IL-1 beta to induce both chemokine expression and nuclear factor-kappa B-dependent apoptosis in pancreatic beta-cells: potential mechanisms for viral-induced insulitis and beta-cell death in type 1 diabetes mellitus. Endocrinology143, 1225–1234 (2002). ArticleCASPubMed Google Scholar
Dogusan, Z. et al. Double-stranded RNA induces pancreatic beta-cell apoptosis by activation of the toll-like receptor 3 and interferon regulatory factor 3 pathways. Diabetes57, 1236–1245 (2008). ArticleCASPubMed Google Scholar
Stewart, T. A. et al. Induction of type 1 diabetes by interferon-alpha in transgenic mice. Science260, 1942–1946 (1993). ArticleCASPubMed Google Scholar
Chakrabarti, D., Hultgren, B. & Stewart, T. A. IFN-alpha induces autoimmune T cells through the induction of intracellular adhesion molecule-1 and B7.2. J. Immunol.157, 522–528 (1996). CASPubMed Google Scholar
Scarim, A. L. et al. Mechanisms of beta-cell death in response to double-stranded (ds) RNA and interferon-gamma: dsRNA-dependent protein kinase apoptosis and nitric oxide-dependent necrosis. Am. J. Pathol.159, 273–283 (2001). ArticleCASPubMedPubMed Central Google Scholar
Flodström-Tullberg, M. et al. RNase L and double-stranded RNA-dependent protein kinase exert complementary roles in islet cell defense during coxsackievirus infection. J. Immunol.174, 1171–1177 (2005). ArticlePubMed Google Scholar
Colbère-Garapin, F. in Molecular Biology of Picornaviruses (eds Semler, B. L. & Wimmer, E.) (American Society for Microbiology, Washington DC, 2002). Google Scholar
Frisk, G., Jansson, K., Ericsson, M. & Diderholm, H. Differences in inhibition of replication between Coxsackie B4 virus strains in various cell lines by antibodies to some cell surface proteins. Virus Res.73, 121–130 (2001). ArticleCASPubMed Google Scholar
Skarsvik, S. et al. Decreased in vitro type 1 immune response against coxsackie virus B4 in children with type 1 diabetes. Diabetes55, 996–1003 (2006). ArticleCASPubMed Google Scholar
See, D. M. & Tilles, J. G. Pathogenesis of virus-induced diabetes in mice. J. Infect. Dis.171, 1131–1138 (1995). ArticleCASPubMed Google Scholar
Merkler, D. et al. “Viral déjà vu” elicits organ-specific immune disease independent of reactivity to self. J. Clin. Invest.116, 1254–1263 (2006). ArticleCASPubMedPubMed Central Google Scholar
von Herrath, M., Sanda, S. & Herold, K. Type 1 diabetes as a relapsing–remitting disease? Nat. Rev. Immunol.7, 988–994 (2007). ArticleCASPubMed Google Scholar
Lehmann, P. V., Sercarz, E. E., Forsthuber, T., Dayan, C. M. & Gammon, G. Determinant spreading and the dynamics of the autoimmune T-cell repertoire. Immunol. Today14, 203–208 (1993). ArticleCASPubMed Google Scholar
Paronen, J. et al. Glutamate decarboxylase-reactive peripheral blood lymphocytes from patients with IDDM express gut-specific homing receptor alpha4beta7-integrin. Diabetes46, 583–588 (1997). ArticleCASPubMed Google Scholar
Horwitz, M. S. et al. Diabetes induced by Coxsackie virus: initiation by bystander damage and not molecular mimicry. Nat. Med.4, 781–785 (1998). ArticleCASPubMed Google Scholar
Serreze, D. V., Ottendorfer, E. W., Ellis, T. M., Gauntt, C. J. & Atkinson, M. A. Acceleration of type 1 diabetes by a coxsackievirus infection requires preexisting critical mass of autoreactive T-cells in pancreatic islets. Diabetes49, 708–711 (2000). ArticleCASPubMed Google Scholar
Horwitz, M. S., Fine, C., Ilic, A. & Sarvetnick, N. Requirements for viral-mediated autoimmune diabetes: beta-cell damage and immune infiltration. J. Autoimmun.16, 211–217 (2001). ArticleCASPubMed Google Scholar
Horwitz, M. S., Ilic, A., Fine, C., Rodriguez, E. & Sarvetnick, N. Presented antigen from damaged pancreatic beta cells activates autoreactive T cells in virus-mediated autoimmune diabetes. J. Clin. Invest.109, 79–87 (2002). ArticleCASPubMedPubMed Central Google Scholar
Christen, U. & von Herrath, M. G. Induction, acceleration or prevention of autoimmunity by molecular mimicry. Mol. Immunol.40, 1113–1120 (2004). ArticleCASPubMed Google Scholar
Vreugdenhil, G. R. et al. Molecular mimicry in diabetes mellitus: the homologous domain in coxsackie B virus protein 2C and islet autoantigen GAD65 is highly conserved in the coxsackie B-like enteroviruses and binds to the diabetes associated HLA-DR3 molecule. Diabetologia41, 40–46 (1998). ArticleCASPubMed Google Scholar
Schloot, N. C. et al. Molecular mimicry in type 1 diabetes mellitus revisited: T-cell clones to GAD65 peptides with sequence homology to Coxsackie or proinsulin peptides do not crossreact with homologous counterpart. Hum. Immunol.62, 299–309 (2001). ArticleCASPubMed Google Scholar
Härkönen, T. et al. Enterovirus infection may induce humoral immune response reacting with islet cell autoantigens in humans. J. Med. Virol.69, 426–440 (2003). ArticlePubMedCAS Google Scholar
Oldstone, M. B., Nerenberg, M., Southern, P., Price, J. & Lewicki, H. Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: role of anti-self (virus) immune response. Cell65, 319–331 (1991). ArticleCASPubMed Google Scholar
Christen, U., Hintermann, E., Holdener, M. & von Herrath, M. G. Viral triggers for autoimmunity: Is the 'glass of molecular mimicry' half full or half empty? J. Autoimmun.34, 38–44 (2010). ArticleCASPubMed Google Scholar
Sevilla, N. et al. Virus-induced diabetes in a transgenic model: role of cross-reacting viruses and quantitation of effector T cells needed to cause disease. J. Virol.74, 3284–3292 (2000). ArticleCASPubMedPubMed Central Google Scholar
Christen, U. et al. A viral epitope that mimics a self antigen can accelerate but not initiate auto-immune diabetes. J. Clin. Invest.114, 1290–1298 (2004). ArticleCASPubMedPubMed Central Google Scholar
Brehm, M. A. et al. T cell immunodominance and maintenance of memory regulated by unexpectedly cross-reactive pathogens. Nat. Immunol.3, 627–634 (2002). ArticleCASPubMed Google Scholar
Filippi, C. M., Estes, E. A., Oldham, J. E. & von Herrath, M. G. Immunoregulatory mechanisms triggered by viral infections protect from type 1 diabetes in mice. J. Clin. Invest.119, 1515–1523 (2009). CASPubMedPubMed Central Google Scholar
Ansari, M. J. et al. The programmed death–1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice. J. Exp. Med.198, 63–69 (2003). ArticleCASPubMedPubMed Central Google Scholar
Fife, B. T. et al. Insulin-induced remission in new-onset NOD mice is maintained by the PD-1-PD-L1 pathway. J. Exp. Med.203, 2737–2747 (2006). ArticleCASPubMedPubMed Central Google Scholar
Zipris, D. et al. Infections that induce autoimmune diabetes in BBDR rats modulate CD4+CD25+ T cell populations. J. Immunol.170, 3592–3602 (2003). ArticleCASPubMed Google Scholar
Johnston, C. et al. Alterations in T-lymphocyte subpopulations in type I diabetes. Exploration of genetic influence in identical twins. Diabetes37, 1484–1488 (1988). ArticleCASPubMed Google Scholar
Faustman, D., Schoenfeld, D. & Ziegler, R. T-lymphocyte changes linked to autoantibodies. Association of insulin autoantibodies with CD4+CD45R+ lymphocyte subpopulation in prediabetic subjects. Diabetes40, 590–597 (1991). ArticleCASPubMed Google Scholar
Chatterjee, N. K., Hou, J., Dockstader, P. & Charbonneau, T. Coxsackievirus B4 infection alters thymic, splenic, and peripheral lymphocyte repertoire preceding onset of hyperglycemia in mice. J. Med. Virol.38, 124–131 (1992). ArticleCASPubMed Google Scholar
Brilot, F., Jaïdane, H., Geenen, V. & Hober, D. Coxsackievirus B4 infection of murine foetal thymus organ cultures. J. Med. Virol.80, 659–666 (2008). ArticleCASPubMed Google Scholar
Brilot, F., Geenen, V., Hober, D. & Stoddart, C. A. Coxsackievirus B4 infection of human fetal thymus cells. J. Virol.78, 9854–9861 (2004). ArticleCASPubMedPubMed Central Google Scholar
Sauter, P. & Hober, D. Mechanisms and results of the antibody-dependent enhancement of viral infections and role in the pathogenesis of coxsackievirus B-induced diseases. Microbes Infect.11, 443–451 (2009). ArticleCASPubMed Google Scholar
Girn, J., Kavoosi, M. & Chantler, J. Enhancement of coxsackievirus B3 infection by antibody to a different coxsackievirus strain. J. Gen. Virol.83, 351–358 (2002). ArticleCASPubMed Google Scholar
Kishimoto, C., Kurokawa, M. & Ochiai, H. Antibody-mediated immune enhancement in coxsackievirus B3 myocarditis. J. Mol. Cell. Cardiol.34, 1227–1238 (2002). ArticleCASPubMed Google Scholar
Hober, D., Chehadeh, W., Bouzidi, A. & Wattré, P. Antibody-dependent enhancement of coxsackievirus B4 infectivity of human peripheral blood mononuclear cells results in increased interferon-alpha synthesis. J. Infect. Dis.184, 1098–1108 (2001). ArticleCASPubMed Google Scholar
Hober, D. et al. Circulating and cell-bound antibodies increase coxsackievirus B4-induced production of IFN-alpha by peripheral blood mononuclear cells from patients with type 1 diabetes. J. Gen. Virol.83, 2169–2176 (2002). ArticleCASPubMed Google Scholar
Chehadeh, W. et al. Viral protein VP4 is a target of human antibodies enhancing coxsackievirus B4- and B3-induced synthesis of alpha interferon. J. Virol.79, 13882–13891 (2005). ArticleCASPubMedPubMed Central Google Scholar
Sauter, P. et al. Role of the capsid protein VP4 in the plasma-dependent enhancement of the Coxsackievirus B4E2-infection of human peripheral blood cells. Virus Res.125, 183–190 (2007). ArticleCASPubMed Google Scholar
Sauter, P. et al. A part of the VP4 capsid protein exhibited by coxsackievirus B4 E2 is the target of antibodies contained in plasma from patients with type 1 diabetes. J. Med. Virol.80, 866–878 (2008). ArticleCASPubMed Google Scholar
Mardis, E. R. The impact of next-generation sequencing technology on genetics. Trends Genet.24, 133–141 (2008). ArticleCASPubMed Google Scholar
Concannon, P., Risch, S. S. & Nepom, G. T. Genetics of type 1A diabetes. N. Engl. J. Med.360, 1646–1654 (2009). ArticleCASPubMed Google Scholar
Ueda, H. et al. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature423, 506–511 (2003). ArticleCASPubMed Google Scholar
Lowe, C. E. et al. Large-scale genetic fine mapping and genetic-phenotype associations implicate polymorphism in the IL2RA region in type 1 diabetes. Nat. Genet.39, 1074–1082 (2007). ArticleCASPubMed Google Scholar
Field, L. L. et al. OAS1 splice site polymorphism controlling antiviral enzyme activity influences susceptibility to type 1 diabetes. Diabetes54, 1588–1591 (2005). ArticleCASPubMed Google Scholar
Bonnevie-Nielsen, V. et al. Variation in antiviral 2′, 5′-oligoadenylate synthetase (2′5′OAS) enzyme activity is controlled by a single-nucleotide polymorphism at a splice-acceptor site in the OAS1 gene. Am. J. Hum. Genet.76, 623–633 (2005). ArticleCASPubMedPubMed Central Google Scholar
Ghosh, A., Sarkar, S. N., Rowe, T. M. & Sen, G. C. A specific isozyme of 2′-5′ oligoadenylate synthetase is a dual function proapoptotic protein of the Bcl-2 family. J. Biol. Chem.276, 25447–25455 (2001). ArticleCASPubMed Google Scholar
Burton, P. R. et al. Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat. Genet.39, 1329–1337 (2006). Google Scholar
Nejentsev, S., Walker, N., Riches, D., Egholm, M. & Todd, J. A. Rare variants of IFIH1, a gene implicated in antiviral responses, protect against type 1 diabetes. Science324, 387–389 (2009). ArticleCASPubMedPubMed Central Google Scholar
Shigemoto, T. et al. Identification of loss of function mutations in human genes encoding RIG-I and MDA5: implications for resistance to type I diabetes. J. Biol. Chem.284, 13348–13354 (2009). ArticleCASPubMedPubMed Central Google Scholar
Yoneyama, M. et al. Shared and unique functions of the DExD/H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity. J. Immunol.175, 2851–2858 (2005). ArticleCASPubMed Google Scholar
Meylan, E., Tschopp, J. & Karin, M. Intracellular pattern recognition receptors in the host response. Nature442, 39–44 (2006). ArticleCASPubMed Google Scholar
Liu, S. et al. IFIH1 polymorphisms are significantly associated with type 1 diabetes and IFIH1 gene expression in peripheral blood mononuclear cells. Hum. Mol. Genet.18, 358–365 (2009). ArticleCASPubMed Google Scholar
Gröschel, S. et al. TLR-mediated induction of negative regulatory ligands on dendritic cells. J. Mol. Med.86, 443–455 (2008). ArticlePubMedCAS Google Scholar
Viskari, H. et al. Relationship between the incidence of type 1 diabetes and enterovirus infections in different European populations: results from the EPIVIR project. J. Med. Virol.72, 610–617 (2004). ArticlePubMed Google Scholar
von Herrath, M. Can we learn from viruses how to prevent type 1 diabetes? The role of viral infections in the pathogenesis of type 1 diabetes and the development of novel combination therapies. Diabetes58, 2–11 (2009). ArticleCASPubMedPubMed Central Google Scholar
Kawai, T. & Akira, S. Toll-like receptor and RIG-I-like receptor signaling. Ann. NY Acad. Sci.1143, 1–20 (2008). ArticleCASPubMed Google Scholar
Colli, M. L., Moore, F., Gurzov, E. N., Ortis, F. & Eizirik D. L. MDA5 and PTPN2, two candidate genes for type 1 diabetes, modify pancreatic beta-cell responses to the viral by-product double stranded RNA. Hum. Mol. Genet.19, 135–146 (2010). ArticleCASPubMed Google Scholar